Novartis CEO plays down prospects for Actelion bid - Blick

VIENNA, Dec 4 (Reuters) - Novartis Chief Executive

Joe Jimenez has played down suggestions the Swiss drugmaker

could bid for Swiss biotech group Actelion, which is in

talks with U.S. healthcare group...

Read more